The partnership among three research and data specialists is aimed at creating a global database to support faster development of novel cancer treatments.
Cancer Research UK to support the clinical development of Hummingbird’s investigative cancer treatment which has the potential to fight drug resistant tumours.
Scancell and Cancer Research UK use nanodelivery technology to activate the body’s immune system, boosting its ability to target and destroy cancer cells.
Cancer Research UK, the world’s largest charitable funder of cancer research, has selected Medidata’s clinical cloud to support the charity’s drug discovery research.
A group of scientists are using real-world experimental data to
generate a virtual model of the human immune system, which could
then be used in drug design.
Researchers in the UK have devised a means of using bacteria as a
means of delivering proteins into tumour cells and killing them,
raising the hope that this could form the basis of a new treatment
for cancer.
Two medical charities - Cancer Research UK and the Netherlands
Cancer Institute - have completed the first stage of a pioneering
initiative to systematically uncover the function of human genes.
